By Erin Fuchs ( March 17, 2010, 5:42 PM EDT) -- Purdue Pharma LP has settled a slew of suits brought by indirect buyers of OxyContin accusing it of stifling generic competition by filing bogus patent litigation, just days after its lawyer told a judge that the drugmaker anticipates settling all of the pending cases in the multidistrict litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.